A study focusing on SEC62 expression in dysplastic cervical lesions91 found SEC62 amplifications in 23% and increased Sec62 protein levels in 100% of cervical cancer cases with a gradually increasing SEC62 expression depending on the severity of dysplasia. Here, SEC62 is linked to cervical carcinoma.